ASX:MVPPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
MEDICAL DEVELOPMENTS INTERNATNL ORD
$0.410
$0.010 (2.38%)
Day Range
$0.400 - $0.435
52 Week Range
$0.365 - $0.765
Volume
458.75K
Avg Volume (10D)
57.02K
Market Cap
$46.19M
P/E Ratio
511.90
Price Chart
Market Statistics
Open$0.430
Previous Close$0.420
Day High$0.435
Day Low$0.400
52 Week High$0.765
52 Week Low$0.365
Valuation
Market Cap46.19M
Shares Outstanding112.66M
P/E Ratio (Annual)511.90
Price to Book0.88
Trading Activity
Volume458.75K
Value Traded188.49K
Bid$0.400 × 36,136
Ask$0.415 × 7,200
Performance
1 Day0.00%
5 Day-2.27%
13 Week-5.49%
52 Week-26.50%
YTD-22.52%
Technical Indicators
RSI (14)44.23
50-Day SMA$0.415
200-Day SMA$0.537
Latest News
Biotechnology
Medical Developments International Achieves Positive Cash Flow in Strong Q3 Performance
Medical Developments International posts strong Q3 FY26: revenue $10.5m up 19%, positive cash flow and progress on European paediatric Penthrox approvals.
1 min read
Biotechnology
Medical Developments strikes deal with Daiichi Sankyo to export Penthrox green whistle to China
Medical solutions company Medical Developments International (ASX: MVP) has set out intentions to expand its market presence by signing an exclusive distribution and license agreement with Tokyo-listed Daiichi Sankyo for its Penthrox drug in China, Thailand and Vietnam. According to the terms of the deal, Daiichi Sankyo will pay Medical Developments as much as US$32.5 […]
4 min read
